Paul Appelbaum, MD, says that it may be time to rethink standards for involuntary commitment without necessarily returning to the low bar that existed decades ago.
Meg Haney, PhD, professor of neurobiology (in psychiatry), says that the recently announced reclassification of cannabis will eliminate some of the biggest hurdles to expanded clinical research.
Zachary Blumkin, PsyD, pushes back on the idea that widespread discussion of mental health can cause young people to assume even mild suffering is a sign of a disorder.
David Hellerstein, MD, a professor of clinical psychiatry, notes that patients who come off antidepressants too quickly can experience “brain zaps” and other side effects.
Dr. Pardes, noted psychiatrist and leader at Columbia University, the New York State Psychiatric Institute, and New-York Presbyterian, passed away April 30, 2024. He was 89.
Clinicians have observed “a marked rise in youth anxiety and depression over the same period of time when social media has become so widely used,” Jeremy Veenstra-VanderWeele, MD said.
Liliana Valvano, LMSW, an associate in Psychiatric Social Work at Columbia University Irving Medical Center, works with neurodivergent clients, helping them build rich and fulfilling lives.
